anonymous
Guest
anonymous
Guest
Rather doubt there will be any urgency by the FDA since it's a me to drug at best. Best case opportunity is 9 to 12 months. The government does not work on anyone's timeline.
another CLR for Brixadi. Does anybody knows Braeburn's US based 3rd party manufacturer linked to continued quality related deficiencies that led to this CLR?So did this drug get approved by the FDA today or not?
Any idea when they’ll actually launch?another CLR for Brixadi. Does anybody knows Braeburn's US based 3rd party manufacturer linked to continued quality related deficiencies that led to this CLR?
another CLR for Brixadi. Does anybody knows Braeburn's US based 3rd party manufacturer linked to continued quality related deficiencies that led to this CLR?
Any idea when they’ll actually launch?
I think we’ll launch sooner than later. Remaining hopeful.
Same issue as last time. We’ll launch within the next 2 months.It was the manufacturing, not the product
Same issue as last time. We’ll launch within the next 2 months.
I applied for the Atlanta position.MMMMMmmmaybe somebody should turn off the LinkedIn job postings now?
I applied for the Atlanta position.
I hear approval was held up for other products due to this same manufacturer. Anyone know the other products or what the specific issue is?Pharmaceutics International